Stalking The Deadly Hantavirus: A Study In Teamwork

Editor's Note: This is the first part of a two-part series on hantavirus, the mysterious and lethal microorganism whose sudden appearance in the southwestern United States last year led to the deaths of more than a dozen people and sparked a flurry of activity in the research community. The following article recounts the swift and effective response to the frightening microbe by scientists of various disciplines. The second part of

Written byKaren Kreeger
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

The second part of the series, to appear in the July 25 issue, discusses researchers' ongoing efforts to forestall further outbreaks of hantavirus-related infections.

A lethal killer, untimely death, and hardworking detectives- -all of these were ingredients in the mystery surrounding last year's sudden outbreak of a deadly strain of hantavirus new to science and North America. But more intriguing, say researchers, is the other hantavirus story--the galvanization of seemingly disparate lines of research to solve, in a matter of weeks, one of the United States' most deadly epidemiological enigmas.

Between May and June of last year, physicians and public health specialists confirmed that 13 people--several of them members of the Navajo Nation--had died of a mysterious disease characterized by flu-like symptoms that quickly deteriorated into a dangerous form of adult respiratory distress syndrome. No one had ever seen this pathology before--but, thanks to the sharp investigative work of a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies